LewisRRobertsMDPhD
Gastroenterology • Rochester, MNBiliary Tract Disease, Gastrointestinal Cancer, Hepatology & Liver Transplantation
Liver and Biliary Neoplasia at Mayo Clinic Rochester
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Dept Med
Rochester, MN 55905Phone+1 507-538-4700- Is this information wrong?
Summary
- I am a board certified Gastroenterologist and Hepatologist specializing in the diagnosis and treatment of liver and biliary tract malignancies and liver mass lesions. I completed my Internal Medicine and Gastroenterology training at Mayo Clinic, where I serve as Associate Director of the Predoctoral Masters Degree Program in Clinical and Translational Sciences. My research interests are in hepatobiliary malignancies, spanning the spectrum from basic research into the signaling pathways regulating the growth, progression and metastases of liver and biliary cancers, translational studies of new biomarkers and diagnostic tests for early diagnosis, and epidemiological studies of the risk factors and determinants of development of liver and biliary cancers. I am also actively involved in educational and health policy initiatives to improve the prevention, access to care, and treatment of liver cancer patients in the United States, particularly including immigrant African and Asian communities, as well as in sub-Saharan Africa.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1995 - 1998- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1995
The University of IowaPhD, Physiology and Biophysics, 1986 - 1992
University of Ghana Medical SchoolClass of 1982
Certifications & Licensure
MN State Medical License 1994 - 2025
WI State Medical License 1995 - 2025
IA State Medical License 1995 - 2008- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (AGAF) American Gastroenterological Association, 2008
- Fellow (FACP) American College of Physicians
- Join now to see all
Clinical Trials
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B Start of enrollment: 2011 Feb 01
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xe...Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Melanie Kiem, Ethan V Vang, Yo Han Kim, Xin Luo, Daniel R O'Brien, Sarah A B...> ;Cancers. 2024 Mar 5
- Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America.Hassan, M., Li, D., Han, Y., Byun, J., Hatia, R., Long, E., Choi, J., Kelley, R., Cleary, S., Lok, A., Bracci, P., Permuth, J., Bucur, R., Yuan, J., Singal, A., Jalal,...> ;Hepatology. 2024 Feb 20
- Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.Emiloju, O., Yin, J., Koubek, E., Reid, J., Borad, M., Lou, Y., Seetharam, M., Edelman, M., Sausville, E., Jiang, Y., Kaseb, A., Posey, J., Davis, S., Gores, G., Rober...> ;Investigational New Drugs. 2024 Feb 1
- Join now to see all
Journal Articles
- Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular CarcinomaJennifer Leong, Lewis Roberts, Myron Schwartz, Mindie H Nguyen, Nature
Press Mentions
Blue Faery Gives Liver Cancer Research AwardApril 8th, 2022- The Blue Faery “Love Your Liver” Public Awareness CampaignFebruary 14th, 2022
- ‘Our Goal Is to Achieve a World Without Viral Hepatitis’October 1st, 2021
- Join now to see all
Grant Support
- Regulation Of The Tumor Microenvironment In Hepatocellular CarcinomaNational Cancer Institute2012
- Dysregulation Of The Tumor Microenvironment In Hepatocellular CarcinomaNational Cancer Institute2009–2010
- Molecular Pathogenesis Of Hepatocellular CarcinomaNational Cancer Institute2009
- Molecular Pathogenesis Of Hepatocellular CarcinomaNational Cancer Institute2004–2008
- FRA16D Chromosomal Fragile Site In Liver CarcinogenesisNational Cancer Institute1999–2003
Professional Memberships
- Member
- Fellow
- Fellow
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
